A deep-dive into tirzepatide's weight loss evidence, dual GIP/GLP-1 mechanism, published dosing protocols, side effects, and how it compares to semaglutide.

The claim that BPC-157 is orally bioavailable circulates widely in peptide forums. Here is what the actual literature supports and where the myth breaks down.

A source-anchored review of Selank research protocols for anxiety — doses, routes, durations, reported outcomes, and open questions from published studies.

GLP-1 agonists vs retatrutide for fat loss: head-to-head on efficacy, safety, and practical use. Evidence-based verdict for informed decision-making.